Skip to content
Open in App
McKesson logo

McKesson

web2

McKesson Corporation provides healthcare services in the United States and internationally. It...

Symbol · 1MCK
Company profile

About

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products; delivers products to retail pharmacies, hospitals, long-term care centers, clinics, and institutions; and provides logistics and distribution services for manufacturers. It also provides consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies; gene therapy with InspiroGene, practice consulting, and vaccine distribution services; and technology solutions, as well as research, insights, technologies, and services to improve cancer and specialty care. In addition, the company helps in solving medication access, affordability, and adherence challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies. Further, it offers technology services, which includes electronic prior authorization, prescription price transparency, benefit insight, dispensing support services, patient enrollment, third-party logistics, and wholesale distribution support; medical-surgical supplies, laboratory equipment, pharmaceutical distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, and hospital reference labs, nursing homes, hospice and home health care agencies, government facilities ,and online marketplaces and retailers. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

Explore by sector

Explore this sector

Market identity

Exchange listings

Listing identities only. Orbitrum does not publish live prices or market performance on this public profile.

Progress

Roadmap

Advance the separation of Medical Surgical Solutions

KEY STEP

McKesson implemented transition service agreements on January 1, 2026 to support Medical Surgical Solutions as it prepares to operate as an independent company, advancing the company’s planned separation of the segment.

Roadmap reference

Acquire Precision Medicine Group

KEY STEP

McKesson signed a definitive agreement on August 25, 2026 to acquire Precision Medicine Group for approximately $2.25 billion. Following completion, Precision Medicine Group is expected to report within McKesson’s Oncology & Multispecialty segment and add clinical research and biopharma commercialization capabilities. The transaction remains subject to customary closing conditions, including regulatory clearances.

Roadmap reference
People

Company team

KW

Kathleen Wilson-Thompson

Independent Director

Company leadership profile.

MN

Maria N. Martinez

Independent Director

Company leadership profile.

LM

Lynne M. Doughtie

Independent Director

Company leadership profile.

BS

Brian S. Tyler

CEO & Chairman

Company leadership profile.

BE

Bradley E. Lerman

Independent Director

Company leadership profile.

JH

James Hall Hinton

Independent Director

Company leadership profile.

WR

Webster Roy Dunbar

Independent Director

Company leadership profile.

KM

Kevin M. Ozan

Independent Director

Company leadership profile.

DJ

Dominic J. Caruso

Lead Independent Director

Company leadership profile.

DD

Deborah Dunsire

Independent Director

Company leadership profile.

JL

Julie Louise Gerberding

Independent Director

Company leadership profile.

Expert coverage

1 expert evaluated McKesson.

Orbitrum research

Experts evaluating McKesson

Explore the public profiles of experts who have evaluated this project.

Orbitrum Academy

Learn how to read a project assessment